Polymeric particles for the controlled release of human amylin
✍ Scribed by Luiz Henrique Guerreiro; Daniel Da Silva; Eduardo Ricci-Junior; Wendell Girard-Dias; Camile Moreira Mascarenhas; Mauro Sola-Penna; Kildare Miranda; Luís Maurício T.R. Lima
- Book ID
- 113550584
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 396 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0927-7765
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Because of the ability of polymers to exist in glassy, rubbery or solvent‐swollen forms which have very different diffusion coefficients they are able to be used very effectively to control the release of incorporated drugs. As the polymers can vary from inert __in vivo__ to biodegradab
## Abstract **Summary:** The microphase inversion of water‐insoluble poly(L‐lactide), “poly[(L‐lactide)‐__co__‐glycolide] and polylactide‐__block__‐poly(ethylene oxide)‐__block__‐polylactide from THF to water can result in narrowly distributed stable particles. Gliclazide, a commercial drug, can be
## Abstract Novel polymeric sodium alginate (Na‐Alg) interpenetrating network (IPN) beads have been prepared by crosslinking Na‐Alg blend with gelatin (GE) or egg albumin (EA) using glutaraldehyde (GA) as the crosslinking agent. These beads were used for the controlled release of chlorpyrifos. The